News

AI is poised to improve all areas of healthcare but must be handled responsibly
Patient safety means healthcare sets a particularly high standard for AI integration but the sector is increasingly ...
The 3 Things That Matter for Eli Lilly Now
Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...
Narrow-Moat Medpace Benefits From Rising Outsourcing Demand and Shift Toward Faster-Burning Studies
Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...
Not a doctor? Here are 8 rewarding careers in healthcare you can still pursue
Healthcare offers diverse career paths beyond traditional clinical roles like doctors and nurses. Opportunities abound in ...
The Manila Times4d
Eupraxia Pharmaceuticals Invited to Present at Upcoming Investor Conferences
Eupraxia Pharmaceuticals Inc. ('Eupraxia” or the 'Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...
Frontiers5d
Advances in Immunotherapy and Molecular Characterization of Multiple Myeloma
Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has ...
A Once-in-a-Lifetime Opportunity: This Blue Chip Healthcare Stock Down 50% Could Double Your Money
Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street. Investors looking to strike while the iron is hot can buy beaten-down stocks that appear to have excellent ...